In this review, we describe HCC serum and tissue biomarkers focusing on their clinical utility upon HCC surveillance, early diagnosis, prognosis, and post-treatment assessment. 2. Biomarkers …

2020年12月7日 · Most recently, the gut microbiome has been proposed as potential non-invasive biomarkers for HCC diagnosis. In this review, we summarize the current development of HCC …

In this review we discuss recent advances made in the discovery of molecular biomarkers and their significance in the detection of HCC. We focus on three major classes of biomarkers: …

Several biomarkers in body fluid samples, e.g., plasma, serum, urine or stool, have been uncovered that could be objectively measured for HCC surveillance and diagnosis. Alpha …

2024年11月22日 · Blood-based detection is essential for HCC screening, early diagnosis, prognosis evaluation, and surveillance. Current non-invasive detection strategy including …

2024年9月6日 · Insights are provided to translate the knowledge into potential biomarkers for detection and diagnosis, prognosis, treatment response, and drug resistance indicators in …

1 天前 · The results highlighted CDKN3, PPIA, PRC1, GMNN, and CENPW as potential detection biomarkers for HCC patients. Our research offers novel insights into the diagnosis and …

4 天之前 · Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. Although various therapeutic modalities have been established for HCC, the overall …

3 天之前 · The high heterogeneity of hepatocellular carcinoma (HCC) poses challenges for precision treatment strategies. This study aims to use multi-omics methodologies to better …

2023年9月19日 · Immune-checkpoint inhibitors (ICIs) are now widely used for the treatment of patients with advanced-stage hepatocellular carcinoma (HCC). Two different ICI-containing …